Shares of WisdomTree BioRevolution Fund (BATS:WDNA – Get Free Report) traded up 1.5% during mid-day trading on Wednesday . The company traded as high as $16.01 and last traded at $16.00. 899 shares were traded during trading, The stock had previously closed at $15.76.
WisdomTree BioRevolution Fund Stock Performance
The stock has a fifty day simple moving average of $16.01 and a 200-day simple moving average of $16.20. The stock has a market cap of $2.40 million, a P/E ratio of 16.21 and a beta of 1.20.
Hedge Funds Weigh In On WisdomTree BioRevolution Fund
An institutional investor recently bought a new position in WisdomTree BioRevolution Fund stock. Jane Street Group LLC bought a new stake in WisdomTree BioRevolution Fund (BATS:WDNA – Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 13,134 shares of the company’s stock, valued at approximately $217,000. Jane Street Group LLC owned about 8.76% of WisdomTree BioRevolution Fund as of its most recent filing with the Securities and Exchange Commission (SEC).
WisdomTree BioRevolution Fund Company Profile
The WisdomTree BioRevolution Fund (WDNA) is an exchange-traded fund that is based on the WisdomTree BioRevolution index. The fund tracks a modified equally-weighted index of companies in developed markets that focus on the advancements in genetics and biotechnology. WDNA was launched on Jun 3, 2021 and is managed by WisdomTree.
Featured Articles
- Five stocks we like better than WisdomTree BioRevolution Fund
- How Investors Can Find the Best Cheap Dividend Stocks
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Insider Trades May Not Tell You What You Think
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for WisdomTree BioRevolution Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WisdomTree BioRevolution Fund and related companies with MarketBeat.com's FREE daily email newsletter.